BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31432503)

  • 1. Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation.
    Kim H; Walsh MC; Yu J; Laskoski P; Takigawa K; Takegahara N; Choi Y
    FEBS Lett; 2020 Jan; 594(1):144-152. PubMed ID: 31432503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.
    Kim H; Walsh MC; Takegahara N; Middleton SA; Shin HI; Kim J; Choi Y
    Sci Rep; 2017 Mar; 7(1):196. PubMed ID: 28298636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.
    Saha K; Eckert RL
    J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.
    Dong Y; Song C; Wang Y; Lei Z; Xu F; Guan H; Chen A; Li F
    Cell Signal; 2017 Jun; 34():55-65. PubMed ID: 28302565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis.
    Kim H; Kajikawa T; Walsh MC; Takegahara N; Jeong YH; Hajishengallis G; Choi Y
    BMB Rep; 2018 Sep; 51(9):468-473. PubMed ID: 30103845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis.
    Wei TY; Hsia JY; Chiu SC; Su LJ; Juan CC; Lee YC; Chen JM; Chou HY; Huang JY; Huang HM; Yu CT
    Cell Signal; 2014 Dec; 26(12):2940-50. PubMed ID: 25277535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
    Ezeka G; Adhikary G; Kandasamy S; Friedberg JS; Eckert RL
    Mol Carcinog; 2021 Jul; 60(7):429-439. PubMed ID: 33872411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex.
    Abe Y; Suzuki Y; Kawamura K; Tanaka N
    Commun Biol; 2019; 2():23. PubMed ID: 30675521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.
    Asberry AM; Cai X; Deng X; Santiago U; Liu S; Sims HS; Liang W; Xu X; Wan J; Jiang W; Camacho CJ; Dai M; Hu CD
    J Med Chem; 2022 Oct; 65(20):13793-13812. PubMed ID: 36206451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.
    Saha K; Fisher ML; Adhikary G; Grun D; Eckert RL
    Carcinogenesis; 2017 Aug; 38(8):827-836. PubMed ID: 28854561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors.
    Sun LF; Liu Y; Wang J; Huang LD; Yang Y; Cheng XY; Fan YZ; Zhu MX; Liang H; Tian Y; Wang HS; Guo CR; Yu Y
    J Biol Chem; 2019 Dec; 294(51):19589-19603. PubMed ID: 31727741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 Can Compensate for IgSF11 Deficiency by Associating with the Scaffold Protein PSD-95 during Osteoclast Differentiation.
    Kim H; Takegahara N; Walsh MC; Choi Y
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Proteins Interacting with Prmt5 in Medaka (Oryzias latipes) Identified by Yeast Two-Hybridization.
    Shen H; Zhang X; Al Hafiz MA; Liang X; Yao Q; Guo M; Xu G; Zhong X; Zhou Q; Zhao H
    Protein Pept Lett; 2020; 27(10):971-978. PubMed ID: 32370700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
    Wang M; Fuhrmann J; Thompson PR
    Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.
    Chatterjee B; Ghosh K; Suresh L; Kanade SR
    Mol Cell Biochem; 2019 May; 455(1-2):73-90. PubMed ID: 30392062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Structure and Function of the PRMT5:MEP50 Complex.
    Antonysamy S
    Subcell Biochem; 2017; 83():185-194. PubMed ID: 28271477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
    Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mep50 in adult and embryos of medaka fish (Oryzias latipes).
    Cheng N; Guo M; Chang P; Zhang X; Zhang R; Qi C; Zhong X; Zhou Q; Zhao H
    Fish Physiol Biochem; 2016 Jun; 42(3):1053-61. PubMed ID: 26749004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.
    King BF
    Purinergic Signal; 2023 Jun; 19(2):421-439. PubMed ID: 36279087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.